• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

漏出性恶性胸腔积液的临床意义是什么?

What is the clinical significance of transudative malignant pleural effusion?

作者信息

Ryu Jeong-Seon, Ryu Seong-Tae, Kim Young-Shin, Cho Jae-Hwa, Lee Hong-Lyeol

机构信息

Department of Internal Medicine, College of Medicine, Inha University, Incheon, Korea.

出版信息

Korean J Intern Med. 2003 Dec;18(4):230-3. doi: 10.3904/kjim.2003.18.4.230.

DOI:10.3904/kjim.2003.18.4.230
PMID:14717231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4531644/
Abstract

BACKGROUND

A few reports of transudative malignant effusion on a small number of patients have suggested the need to perform routine cytologic examination in all cases of transudative pleural effusion, whether encountered for malignancy or not. The purpose of this study was to investigate whether cytologic examination should be performed in all cases of transudative pleural effusion for the diagnosis of malignancy.

METHODS

We performed a retrospective study of 229 consecutive patients with malignant pleural effusion, proven either cytologically or with biopsy. In patients with transudative pleural effusion, we reviewed medical records, results of transthoracic echocardiography, fiberoptic bronchoscopy, chest X-ray, chest CT scan, and ultrasonogram of the abdomen. These data were examined with particular attention to identifying whether or not the malignancy was suggested on chest X-ray, examining the involvement of the superior vena cava, great vessels, and lymph nodes, determining the presence of pericardial effusion, and observing the endobronchial obstruction.

RESULTS

Transudative malignant pleural effusion was observed in seven (3.1%) of the 229 patients, and was caused either by the malignancy itself (6 patients) or by coexisting cardiac diseases (1 patient). All the patients showed evidence suggesting the presence of malignancy at the time of initial thoracentesis, which facilitated the decision of most clinicians on whether to perform cytologic examination for the diagnosis of malignancy.

CONCLUSION

Therefore, in all cases of transudative pleaural effusion, no clinical implications indicating malignancy were found on cytologic examination.

摘要

背景

少数关于少量患者漏出性恶性胸腔积液的报告表明,对于所有漏出性胸腔积液病例,无论是否因恶性肿瘤所致,都有必要进行常规细胞学检查。本研究的目的是调查是否应对所有漏出性胸腔积液病例进行细胞学检查以诊断恶性肿瘤。

方法

我们对229例经细胞学或活检证实的恶性胸腔积液患者进行了一项回顾性研究。对于漏出性胸腔积液患者,我们查阅了病历、经胸超声心动图、纤维支气管镜检查、胸部X线、胸部CT扫描和腹部超声检查结果。特别关注这些数据,以确定胸部X线是否提示恶性肿瘤、检查上腔静脉、大血管和淋巴结的受累情况、确定心包积液的存在以及观察支气管内阻塞情况。

结果

229例患者中有7例(3.1%)出现漏出性恶性胸腔积液,其原因要么是恶性肿瘤本身(6例),要么是并存的心脏疾病(1例)。所有患者在初次胸腔穿刺时均有提示恶性肿瘤存在的证据,这有助于大多数临床医生决定是否进行细胞学检查以诊断恶性肿瘤。

结论

因此,在所有漏出性胸腔积液病例中,细胞学检查未发现提示恶性肿瘤的临床征象。

相似文献

1
What is the clinical significance of transudative malignant pleural effusion?漏出性恶性胸腔积液的临床意义是什么?
Korean J Intern Med. 2003 Dec;18(4):230-3. doi: 10.3904/kjim.2003.18.4.230.
2
Cytologically proved malignant pleural effusions: distribution of transudates and exudates.经细胞学证实的恶性胸腔积液:漏出液与渗出液的分布情况
Chest. 1998 May;113(5):1302-4. doi: 10.1378/chest.113.5.1302.
3
Transudative malignant pleural effusions: prevalence and mechanisms.漏出性恶性胸腔积液:患病率及机制
South Med J. 1998 Jan;91(1):23-6. doi: 10.1097/00007611-199801000-00004.
4
Transudates in malignancy: still a role for pleural fluid.恶性肿瘤中的漏出液:胸腔积液仍有其作用。
Ann Acad Med Singap. 2008 Sep;37(9):760-3.
5
Clinically occult primary fallopian tube carcinoma presenting as a malignant pleural effusion.以恶性胸腔积液为表现的临床隐匿性原发性输卵管癌。
Clin Respir J. 2017 Nov;11(6):1086-1090. doi: 10.1111/crj.12423. Epub 2016 Jan 4.
6
Malignant transient pleural transudate: a sign of early lymphatic tumoral obstruction.
Respiration. 2000;67(3):333-6. doi: 10.1159/000029522.
7
Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion.基于1H-核磁共振波谱代谢谱的结核性、恶性和漏出性胸腔积液的代谢组学分析。
Mol Med Rep. 2017 Aug;16(2):1147-1156. doi: 10.3892/mmr.2017.6758. Epub 2017 Jun 12.
8
The diagnostic yield of pleural fluid cytology in malignant pleural effusions.恶性胸腔积液中胸腔积液细胞学检查的诊断阳性率。
Singapore Med J. 2000 Jan;41(1):19-23.
9
Positivity of pleural fluid cytologic examination in transudative pleural effusions.漏出性胸腔积液中胸腔积液细胞学检查的阳性率
Chest. 1998 Dec;114(6):1798-9. doi: 10.1378/chest.114.6.1798-a.
10
Should a cytologic study be ordered in transudative pleural effusions?
Chest. 1999 Dec;116(6):1836-7. doi: 10.1378/chest.116.6.1836.

引用本文的文献

1
Malignant Pleural Effusion: Diagnosis and Treatment-Up-to-Date Perspective.恶性胸腔积液:诊断与治疗——最新视角。
Curr Oncol. 2024 Nov 2;31(11):6867-6878. doi: 10.3390/curroncol31110507.
2
Lipoprotein profile of pleural and peritoneal transudates in dogs and cats.犬猫胸腔和腹腔渗出液的脂蛋白谱。
J Vet Intern Med. 2022 Mar;36(2):464-472. doi: 10.1111/jvim.16369. Epub 2022 Feb 15.
3
GC-MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion.GC-MS 代谢组学鉴定出新型生物标志物,可区分结核性胸腔积液与恶性胸腔积液。
J Clin Lab Anal. 2021 Apr;35(4):e23706. doi: 10.1002/jcla.23706. Epub 2021 Feb 2.
4
Transudative pleural effusion of malignant etiology: Rare but real.恶性病因的漏出性胸腔积液:罕见但确实存在。
Respir Med Case Rep. 2017 Feb 28;20:188-191. doi: 10.1016/j.rmcr.2017.02.015. eCollection 2017.
5
Predictive models of malignant transudative pleural effusions.恶性漏出性胸腔积液的预测模型。
J Thorac Dis. 2017 Jan;9(1):106-116. doi: 10.21037/jtd.2017.01.12.
6
Diagnostic pitfalls of discriminating lymphoma-associated effusions.鉴别淋巴瘤相关积液的诊断陷阱。
Medicine (Baltimore). 2015 May;94(17):e800. doi: 10.1097/MD.0000000000000800.
7
Malignant pleural effusion: medical approaches for diagnosis and management.恶性胸腔积液:诊断与管理的医学方法
Tuberc Respir Dis (Seoul). 2014 May;76(5):211-7. doi: 10.4046/trd.2014.76.5.211. Epub 2014 May 29.
8
The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.血管内皮生长因子在恶性胸腔积液发病机制、诊断和治疗中的作用。
Curr Oncol Rep. 2013 Jun;15(3):207-16. doi: 10.1007/s11912-013-0315-7.

本文引用的文献

1
RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS.
Cancer. 1964 Jul;17:914-28. doi: 10.1002/1097-0142(196407)17:7<914::aid-cncr2820170712>3.0.co;2-6.
2
Transudative pleural effusions: false reassurance against malignancy.漏出性胸腔积液:对恶性肿瘤的错误安心。
Chest. 2000 Sep;118(3):885. doi: 10.1378/chest.118.3.885.
3
Malignant transient pleural transudate: a sign of early lymphatic tumoral obstruction.
Respiration. 2000;67(3):333-6. doi: 10.1159/000029522.
4
Should a cytologic study be ordered in transudative pleural effusions?
Chest. 1999 Dec;116(6):1836-7. doi: 10.1378/chest.116.6.1836.
5
Cytology on transudative pleural effusions.
Chest. 1999 Sep;116(3):846-7. doi: 10.1378/chest.116.3.846.
6
Positivity of pleural fluid cytologic examination in transudative pleural effusions.漏出性胸腔积液中胸腔积液细胞学检查的阳性率
Chest. 1998 Dec;114(6):1798-9. doi: 10.1378/chest.114.6.1798-a.
7
Cytologically proved malignant pleural effusions.经细胞学证实的恶性胸腔积液。
Chest. 1998 Dec;114(6):1798. doi: 10.1378/chest.114.6.1798.
8
Malignancy metastatic to the pleura.转移至胸膜的恶性肿瘤。
Clin Chest Med. 1998 Jun;19(2):351-61. doi: 10.1016/s0272-5231(05)70082-4.
9
Cytologically proved malignant pleural effusions: distribution of transudates and exudates.经细胞学证实的恶性胸腔积液:漏出液与渗出液的分布情况
Chest. 1998 May;113(5):1302-4. doi: 10.1378/chest.113.5.1302.
10
Transudative malignant pleural effusions: prevalence and mechanisms.漏出性恶性胸腔积液:患病率及机制
South Med J. 1998 Jan;91(1):23-6. doi: 10.1097/00007611-199801000-00004.